News in Brief: Allergy, Asthma and Immunology Meeting – Science News


National Post

News in Brief: Allergy, Asthma and Immunology Meeting
Science News
People with hives that recur for years and even decades might get relief from an allergy drug. Called omalizumab and marketed as Xolair, the drug inhibits the rogue antibody immunoglobulin E, which brings on persistent, intense itching and body
C-Section May Raise Child's Risk of Allergies, Asthma: StudyU.S. News & World Report
Environmental factors appear to promote development of allergic diseasesHealio
Researchers share findings on allergies at national meeting in San AntonioSan Antonio Business Journal (blog)
MedPage Today –National Post –ReporterHerald.com
all 28 news articles »

View full post on asthma – Google News